01 July 2022 | News
Akums will get access to markets in the entire European Union as well as many other markets across the world
Akums Drugs & Pharmaceuticals has recently acquired the stringent European Union (EU) Good Manufacturing Practice (GMP) approval for two of their manufacturing units in Haridwar. The gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs.
Akums has received EU GMP approval for two of its manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and the other manufactures the large-volume and small-volume parenterals range including vials, ampoules, eyedrops, FFS as well as dry powder injections belonging to the penicillin line.